These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 22103746)

  • 41. Drug-induced functional cardiotoxicity screening in stem cell-derived human and mouse cardiomyocytes: effects of reference compounds.
    Himmel HM
    J Pharmacol Toxicol Methods; 2013; 68(1):97-111. PubMed ID: 23702537
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Proarrhythmic effects induced by benzethonium chloride and domiphen bromide in vitro and in vivo.
    Long Y; Hou J; Tang F; Lin Z; Huang X; Li W; Chen Y; Li Z; Wu Z
    Toxicol Appl Pharmacol; 2021 Nov; 431():115731. PubMed ID: 34592322
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro electrophysiological drug testing using human embryonic stem cell derived cardiomyocytes.
    Caspi O; Itzhaki I; Kehat I; Gepstein A; Arbel G; Huber I; Satin J; Gepstein L
    Stem Cells Dev; 2009; 18(1):161-72. PubMed ID: 18510453
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Integrating in vitro data and physiologically based kinetic modeling-facilitated reverse dosimetry to predict human cardiotoxicity of methadone.
    Shi M; Bouwmeester H; Rietjens IMCM; Strikwold M
    Arch Toxicol; 2020 Aug; 94(8):2809-2827. PubMed ID: 32367273
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased cardiac risk in concomitant methadone and diazepam treatment: pharmacodynamic interactions in cardiac ion channels.
    Kuryshev YA; Bruening-Wright A; Brown AM; Kirsch GE
    J Cardiovasc Pharmacol; 2010 Oct; 56(4):420-30. PubMed ID: 20930594
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Use of Voltage Sensitive Dye di-4-ANEPPS and Video-Based Contractility Measurements to Assess Drug Effects on Excitation-Contraction Coupling in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Hortigon-Vinagre MP; Zamora V; Burton FL; Smith GL
    J Cardiovasc Pharmacol; 2021 Mar; 77(3):280-290. PubMed ID: 33109927
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comprehensive in vitro Proarrhythmia Assay, a novel in vitro/in silico paradigm to detect ventricular proarrhythmic liability: a visionary 21st century initiative.
    Cavero I; Holzgrefe H
    Expert Opin Drug Saf; 2014 Jun; 13(6):745-58. PubMed ID: 24845945
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Disease characterization using LQTS-specific induced pluripotent stem cells.
    Egashira T; Yuasa S; Suzuki T; Aizawa Y; Yamakawa H; Matsuhashi T; Ohno Y; Tohyama S; Okata S; Seki T; Kuroda Y; Yae K; Hashimoto H; Tanaka T; Hattori F; Sato T; Miyoshi S; Takatsuki S; Murata M; Kurokawa J; Furukawa T; Makita N; Aiba T; Shimizu W; Horie M; Kamiya K; Kodama I; Ogawa S; Fukuda K
    Cardiovasc Res; 2012 Sep; 95(4):419-29. PubMed ID: 22739119
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes.
    Braam SR; Tertoolen L; van de Stolpe A; Meyer T; Passier R; Mummery CL
    Stem Cell Res; 2010 Mar; 4(2):107-16. PubMed ID: 20034863
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Usefulness of cardiotoxicity assessment using calcium transient in human induced pluripotent stem cell-derived cardiomyocytes.
    Watanabe H; Honda Y; Deguchi J; Yamada T; Bando K
    J Toxicol Sci; 2017; 42(4):519-527. PubMed ID: 28717111
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comprehensive Cardiac Safety Assessment using hiPS-cardiomyocytes (Consortium for Safety Assessment using Human iPS Cells: CSAHi).
    Takasuna K; Kazusa K; Hayakawa T
    Curr Pharm Biotechnol; 2020; 21(9):829-841. PubMed ID: 31749424
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiotoxicity screening: a review of rapid-throughput in vitro approaches.
    Li X; Zhang R; Zhao B; Lossin C; Cao Z
    Arch Toxicol; 2016 Aug; 90(8):1803-16. PubMed ID: 26676948
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of IKr and its trafficking disruption induced by probucol in cultured neonatal rat cardiomyocytes.
    Guo J; Massaeli H; Li W; Xu J; Luo T; Shaw J; Kirshenbaum LA; Zhang S
    J Pharmacol Exp Ther; 2007 Jun; 321(3):911-20. PubMed ID: 17377062
    [TBL] [Abstract][Full Text] [Related]  

  • 54. hERG potassium channels and cardiac arrhythmia.
    Sanguinetti MC; Tristani-Firouzi M
    Nature; 2006 Mar; 440(7083):463-9. PubMed ID: 16554806
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induced pluripotent stem cells as cardiac arrhythmic in vitro models and the impact for drug discovery.
    Sarić T; Halbach M; Khalil M; Er F
    Expert Opin Drug Discov; 2014 Jan; 9(1):55-76. PubMed ID: 24294840
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HIV Tat protein inhibits hERG K+ channels: a potential mechanism of HIV infection induced LQTs.
    Bai YL; Liu HB; Sun B; Zhang Y; Li Q; Hu CW; Zhu JX; Gong DM; Teng X; Zhang Q; Yang BF; Dong DL
    J Mol Cell Cardiol; 2011 Nov; 51(5):876-80. PubMed ID: 21820442
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Calcium transients closely reflect prolonged action potentials in iPSC models of inherited cardiac arrhythmia.
    Spencer CI; Baba S; Nakamura K; Hua EA; Sears MA; Fu CC; Zhang J; Balijepalli S; Tomoda K; Hayashi Y; Lizarraga P; Wojciak J; Scheinman MM; Aalto-Setälä K; Makielski JC; January CT; Healy KE; Kamp TJ; Yamanaka S; Conklin BR
    Stem Cell Reports; 2014 Aug; 3(2):269-81. PubMed ID: 25254341
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular interaction of droperidol with human ether-a-go-go-related gene channels: prolongation of action potential duration without inducing early afterdepolarization.
    Schwoerer AP; Blütner C; Brandt S; Binder S; Siebrands CC; Ehmke H; Friederich P
    Anesthesiology; 2007 May; 106(5):967-76. PubMed ID: 17457128
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modeling Inherited Arrhythmia Disorders Using Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Bezzerides VJ; Zhang D; Pu WT
    Circ J; 2016 Dec; 81(1):12-21. PubMed ID: 27916777
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A new paradigm for drug-induced torsadogenic risk assessment using human iPS cell-derived cardiomyocytes.
    Ando H; Yoshinaga T; Yamamoto W; Asakura K; Uda T; Taniguchi T; Ojima A; Shinkyo R; Kikuchi K; Osada T; Hayashi S; Kasai C; Miyamoto N; Tashibu H; Yamazaki D; Sugiyama A; Kanda Y; Sawada K; Sekino Y
    J Pharmacol Toxicol Methods; 2017; 84():111-127. PubMed ID: 27956204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.